Search

Quick Filters

Compliance Status
Clear

Clinical Trials Data

Showing 1450 of 543136 entries
View as:

Stress Intervention for Chronic Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT01111136 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT02396953 Org: User:
Start: 03/31/15 End: 11/28/17 Due: 11/28/18

European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study

Phase: N/A Priority: Normal
NCT ID: NCT06235385 Org: User:
Start: 02/07/24 End: 08/01/29 Due: 08/01/30

Juice Plus Supplement Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT04656860 Org: User:
Start: 03/12/20 End: 03/12/23 Due: 03/12/24

Motivational Interviewing in Patients With Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05428241 Org: User:
Start: 07/01/22 End: 12/25/23 Due: 12/25/24

Chemotherapy in Treating Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003698 Org: User:
Start: 07/31/98 End: 12/31/03 Due: 12/31/04

Intranasal Oxytocin for Infants With Prader-Willi Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03245762 Org: User:
Start: 08/01/17 End: 01/04/18 Due: 01/04/19

Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00005469 Org: User:
Start: 09/30/90 End: 11/30/96 Due: 11/30/97

PENG vs. FIC Block for Hip Fracture ED Patients

Phase: N/A Priority: Normal
NCT ID: NCT05102760 Org: User:
Start: 10/20/21 End: 12/31/25 Due: 12/31/26

Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01282697 Org: User:
Start: 04/22/11 End: 02/20/13 Due: 02/20/14

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02136342 Org: User:
Start: 05/31/14 End: - Due: -

Denosumab vs Zoledronate After Vertebroplasty

Phase: N/A Priority: Normal
NCT ID: NCT05598606 Org: User:
Start: 01/12/21 End: 01/14/23 Due: 01/14/24

A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00873561 Org: User:
Start: 12/31/01 End: 07/31/06 Due: 07/31/07

The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)

Phase: N/A Priority: Normal
NCT ID: NCT05117385 Org: User:
Start: 11/22/21 End: 07/18/22 Due: 07/18/23

Safety Study for an All-in-One Body and Personal Lubricant

Phase: N/A Priority: Normal
NCT ID: NCT01189617 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05569187 Org: User:
Start: 03/23/21 End: 10/29/21 Due: 10/29/22

The Influence of Blood Sampling Technique on the Total Amount of Blood Collected for Laboratory Testing Critically Ill Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT06376747 Org: User:
Start: 05/01/24 End: 08/31/25 Due: 08/31/26

PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health

Phase: N/A Priority: Normal
NCT ID: NCT06186531 Org: User:
Start: 11/17/23 End: 11/15/24 Due: 11/15/25

A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB

Phase: N/A Priority: Normal
NCT ID: NCT06308120 Org: User:
Start: 03/20/24 End: 09/30/26 Due: 09/30/27

A Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-A33/KEYNOTE-A33)

Phase: N/A Priority: Normal
NCT ID: NCT04317066 Org: User:
Start: 06/26/20 End: 04/11/24 Due: 04/11/25

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00021021 Org: User:
Start: 09/30/01 End: 02/29/04 Due: 02/28/05

Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02679079 Org: User:
Start: 03/23/16 End: 04/14/17 Due: 04/14/18

A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

Phase: N/A Priority: Normal
NCT ID: NCT00572793 Org: User:
Start: 11/30/07 End: 07/31/14 Due: 07/31/15

Fiix-prothrombin Time for Monitoring Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01565239 Org: User:
Start: 03/31/12 End: 02/28/14 Due: 02/28/15

A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03745937 Org: User:
Start: 01/07/19 End: 05/28/19 Due: 05/28/20